Risk factors for esotropia reoperation revealed

Article

Underaction of the lateral rectus muscle could be a risk factor for reoperation of congenital esostropia, claims an investigation in the Journal of Pediatric Ophthalmology and Strabismus.

Underaction of the lateral rectus muscle could be a risk factor for reoperation of congenital esostropia, claims an investigation in the Journal of Pediatric Ophthalmology and Strabismus.

Dr Z. Rajavi et al., Ophthalmic Research Centre, Shahid Beheshti University of Medical Sciences, Tehran, Iran, conducted a study on 157 children with congenital esotropia, who were divided into two groups after a minimum of one operation. The patients included those with a deviation greater than 10 PD or a history of reoperation.

Risk factors such as age at first operation and primary congenital esotropia of less than 30 or more than 50 PD inferior oblique muscle overaction, dissociated vertical deviation, lateral rectus muscle underaction, and A-V pattern with reoperation were recorded.

Reoperation was required in 32.4% of children who presented with residual esotrpia greater than 15 PD after the three-month follow-up. Congenital esotropia greater than 30 PD and lateral rectus muscle underaction of −1 to −2 were statistically different between the two groups and were found to be risk factors of reoperation.

Please click here to view the abstract.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.